GB0508356D0 - Materials and methods relating to the diagnosis of cancer - Google Patents

Materials and methods relating to the diagnosis of cancer

Info

Publication number
GB0508356D0
GB0508356D0 GB0508356A GB0508356A GB0508356D0 GB 0508356 D0 GB0508356 D0 GB 0508356D0 GB 0508356 A GB0508356 A GB 0508356A GB 0508356 A GB0508356 A GB 0508356A GB 0508356 D0 GB0508356 D0 GB 0508356D0
Authority
GB
United Kingdom
Prior art keywords
diagnosis
cancer
materials
methods relating
relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0508356A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Technology Ltd
Original Assignee
Cancer Research Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Technology Ltd filed Critical Cancer Research Technology Ltd
Priority to GB0508356A priority Critical patent/GB0508356D0/en
Publication of GB0508356D0 publication Critical patent/GB0508356D0/en
Priority to PCT/GB2006/001510 priority patent/WO2006114611A2/en
Ceased legal-status Critical Current

Links

GB0508356A 2005-04-25 2005-04-25 Materials and methods relating to the diagnosis of cancer Ceased GB0508356D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0508356A GB0508356D0 (en) 2005-04-25 2005-04-25 Materials and methods relating to the diagnosis of cancer
PCT/GB2006/001510 WO2006114611A2 (en) 2005-04-25 2006-04-25 Materials and methods relating to the diagnosis of cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0508356A GB0508356D0 (en) 2005-04-25 2005-04-25 Materials and methods relating to the diagnosis of cancer

Publications (1)

Publication Number Publication Date
GB0508356D0 true GB0508356D0 (en) 2005-06-01

Family

ID=34640099

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0508356A Ceased GB0508356D0 (en) 2005-04-25 2005-04-25 Materials and methods relating to the diagnosis of cancer

Country Status (2)

Country Link
GB (1) GB0508356D0 (en)
WO (1) WO2006114611A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102095854A (en) * 2010-11-30 2011-06-15 中国人民解放军军事医学科学院生物工程研究所 Novel application of CTCF (CCCCCT-binding factor) protein
KR101797282B1 (en) 2015-03-26 2017-11-13 연세대학교 산학협력단 A role of ctcf gene in atopic and allergic disease
CN106913861B (en) * 2017-02-28 2020-02-21 上海交通大学医学院附属第九人民医院 Application of CTCF trap protein in preparation of anti-uveal melanoma drugs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972643A (en) * 1994-06-17 1999-10-26 Fred Hutchinson Cancer Research Center Isolated polynucleotide molecules encoding CTCF, a CCCTC-binding factor

Also Published As

Publication number Publication date
WO2006114611A2 (en) 2006-11-02
WO2006114611A3 (en) 2006-12-21

Similar Documents

Publication Publication Date Title
HUS1700015I1 (en) Antibody against PDGFR-alpha for use in the treatment of tumours
TWI320360B (en) Composite materials and methods of making the same
HK1132302A1 (en) Micrornarna-based methods and compositions for the diagnosis and treatment of solid cancers rna
GB0718972D0 (en) Compounds and methods of making the compounds
HK1138019A1 (en) Human antibodies to human delta like ligand 4
EP1888765A4 (en) Methods and compositions for the diagnosis of venous thromboembolic disease
ZA200710173B (en) Tygecycline and methods of preparing 9-nitrominocycline
EP1968649A4 (en) Protein nanoparticles and the use of the same
EP1931995A4 (en) Methods for the diagnosis of colorectal cancer and ovarian cancer health states
HK1119070A1 (en) Use of trans-clomiphene in the manufacture of medicines
IL185309A0 (en) Isoqunoline compounds and methods of use thereof
EP1937816A4 (en) Markers for diagnosis of cancer and its use
ZA200711105B (en) Novel physiological substance nesfatin substance relevant thereto, and use of the substances
HK1117780A1 (en) Compounds and methods for the treatment of cancer
EP1977003A4 (en) Methods and means related to diseases
EP1904088A4 (en) Compositions and methods for the treatment of cancer
GB0508356D0 (en) Materials and methods relating to the diagnosis of cancer
GB0725141D0 (en) Improvements in and relating to the analysis of pharmaceutical compounds
EP1797430A4 (en) Methods and compositions for the diagnosis and treatment of cancer
GB0515325D0 (en) Improvements relating to the detection of lower limb disease
IL185900A0 (en) Compositions and methods for the diagnosis and treatment of tumor
IL186277A0 (en) Dnt-maleate and methods of preparation thereof
EP1978999A4 (en) Isolated mcpip and methods of use
GB0515892D0 (en) Improvements in or relating to the manufacture of composites
EP1725869A4 (en) Man2as as modifiers of the iger pathway and methods of use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)